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Background: Titanium (Ti) implants are widely used clinically, but peri-implantitis remains 
one of the most common and serious complications. Healthy integration between gingival tissue 
and the implant surface is critical to long-term success in dental implant therapy. The objective 
of this study was to investigate how different concentrations of immobilized fibroblast growth 
factor 2 (FGF2) on the titania nanotubular surface influence the response of human gingival 
fibroblasts (HGFs).
Methods: Pure Ti metal was anodized at 20 V to form a vertically organized titanium 
dioxide nanotube array on which three concentrations of FGF2 (250 ng/mL, 500 ng/mL, or 
1000 ng/mL) were immobilized by repeated lyophilization. Surface topography was observed 
and FGF2 elution was detected using enzyme-linked immunosorbent assay. The bioactivity 
changes of dissolvable immobilized FGF2 were measured by methyl-thiazolyl-tetrazolium 
assay. Behavior of HGFs was evaluated using adhesion and methyl-thiazolyl-tetrazolium 
bromide assays.
Results: The FGF2 remained for several days on the modified surface on which HGFs were 
cultured. Over 90% of the dissolvable immobilized FGF2 had been eluted by Day 9, whereas 
the FGF2 activity was found to diminish gradually from Day 1 to Day 9. The titania nanotubular 
surface with an optimal preparing concentration (500 ng/mL) of FGF2 immobilization 
  exhibited improved HGF functions such as cellular attachment, proliferation, and extracellular 
  matrix-related gene expression. Moreover, significant bidirectional as well as concentration- and 
time-dependent bioactivity was observed.
Conclusion: Synergism of the FGF2-impregnated titanium dioxide nanotubular surface 
revealed good gingival-implant integration, indicating that these materials might have promising 
applications in dentistry and other biomedical devices.
Keywords: dental implants, titanium dioxide nanotube, fibroblast growth factor 2, extracellular 
matrix, real-time polymerase chain reaction
Introduction
Titanium (Ti) and its alloys are widely used in dental implant therapy to treat edentulous 
patients but may suffer from failure due to peri-implantitis and other complications.1–3 
Archival evidence supports the view that the long-term retention of an osseointegrated 
implant is influenced mainly by proper marginal soft tissue sealing4 of the alveolar 
bone below.5,6 Furthermore, the proper dimensions and function of the soft tissue 
seal are prerequisite to therapeutic success.7,8 Recent studies have revealed specific 
differences between the microbial profiles of healthy and diseased dental implants,9,10 
indicating that the loss of balance between the known periodontal pathogens and host-
compatible microbial complexes may contribute to peri-implantitis and reinfection of 
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the subgingival sites.10 A well-formed soft tissue seal reduces 
the exposed area of the subgingival part of the implant and 
may reduce the formation and growth of a biofilm without 
disturbing the microbial balance around the implant.
Although polished Ti (PT) and Ti alloys are used in the 
transgingival part of conventional dental implants, they 
contact only the surrounding soft tissues and do not form a 
healthy seal at the soft tissue-implant interface by themselves. 
Manipulating the structure of Ti is a possible way to enhance 
soft tissue compatibility on Ti dental implants. The shape, 
surface topography, design, physicochemical properties, and 
even the method used to sterilize the Ti implant may affect 
the integration between the implant and soft tissues.11,12 The 
method is quite promising for tissue regeneration, due to 
the well-organized and porous Ti nanostructure that forms 
the biocompatible surface.
A titanium dioxide (TiO2) nanotubular structure can be 
formed on Ti by anodization of a relatively large surface 
area to enable bioactive factor absorption.13,14 According  to 
previous studies, the TiO2 nanotubular structure can affect 
functions such as adhesion, orientation, proliferation, and 
gene expression in various types of cells.14–17 In addition, 
the TiO2 nanotubular surface with a tube size of ∼120 nm 
exhibits better electrochemical stability in artificial saliva 
as well as improved adhesion and proliferation of human 
gingival fibroblasts (HGFs).18
Fibroblast growth factors (FGFs) are a large family of 
polypeptide growth factors that regulate the secretion of 
  various extracellular matrix (ECM) proteins, which   contribute 
to the formation of new blood vessels.19,20 Fibroblast growth 
factor 2 (FGF2) is a potent mitogen in a variety of cells and 
is effective in regulating the proliferation and ECM-related 
gene expression of fibroblasts,21,22 the most common cell type 
in peri-implant gingival connective tissue.
To control the responses of cells and tissues toward 
biomaterials, modification of surfaces and immobilization 
of biomolecules have been widely studied.23 FGF2 can be 
immobilized on Ti surfaces pretreated with oxygen plasma,24 
and the TiO2 nanotubular surface benefits drug control 
release25 and immobilization of other growth factors such as, 
bone morphogenetic protein 2 as well.14 Hence, a TiO2 nano-
tubular surface and FGF2 may be used together to improve 
early gingival tissue-implant integration by enhancing the 
functions of surrounding HGFs. However, according to 
previous studies, the effects of FGF2 may depend on the 
concentration of FGF2 in the culture medium, suggesting 
that improper amounts of FGF2 on the Ti surface may spur 
adverse effects.26 Although the behavior of some cells on 
surfaces with different topographies has been investigated, 
the relationship between the behavior of HGFs around dental 
implants and variable FGF2 immobilization has not been 
systematically studied.27–29 Hence, a better understanding of 
this issue will help to mimic natural gingival tissue-implant 
integration.
In the work reported here, Ti samples were anodized 
at 20 V to form a vertically organized TiO2 nanotubular 
  surface, and FGF2 solutions of three different   concentrations 
were used to immobilize FGF2 on the nanotubular surface 
by repeated lyophilization. The objectives of this study are 
to investigate how different concentrations of   immobilized 
FGF2 on the titania nanotubular surface influence the response 
of HGFs, and to determine the associated mechanism.
Materials and methods
Sample preparation
Pure Ti foils (99.9%, 1000 × 500 × 0.6 mm3, supplied by 
Northwest Institute for Nonferrous Metal Research, Xi’an, 
People’s Republic of China) were cut into 10 × 10 × 0.6 mm3 
pieces, polished with 400- to 1500-grit silicon carbide 
sandpaper in running water, and ultrasonically cleaned in ace-
tone, 70% ethanol, and doubly distilled water for 10 minutes 
sequentially. They were then dried at 50°C for 20 minutes 
under flowing nitrogen. The PT samples were anodized in an 
electrolyte solution containing 0.5% ammonium fluoride and 
1 M ammonium sulfate at 20 V for 45 minutes18 using a Ti 
anode and a PT cathode. During anodization, the electrolyte 
was stirred constantly, and afterwards the samples were 
ultrasonically cleaned and dried as described previously to 
obtain the nanotube (NT) samples.
Immobilization of FgF2
The NT samples were sterilized by ultraviolet A (peak 
wavelength 365 nm, Philips TL-D 18 WBL, the Netherlands) 
and C (peak wavelength 253.7 nm, Philips TUV 15W, 
Poland) irradiation at a distance of 30 mm for 2 hours 
each, because ultraviolet sterilization inactivates bacteria 
without organic contamination and decomposes existing 
organic species on the titania surface by photocatalysis.30 
The Escherichia coli source recombinant human FGF2 
  (Peprotech, UK) was reconstituted in Tris-HCl buffered 
solution (pH 7.6, Sigma-Aldrich, St, Louis, MO) with 
0.1% bovine serum album (Gibco, US). The FGF2 was 
diluted to 250 ng/mL, 500 ng/mL, or 1000 ng/mL. The 
NT samples were divided into three groups designated as 
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NT-F-L, NT-F-M, and NT-F-H, corresponding respectively 
to the FGF2   concentrations. Each group was incubated in the 
appropriate FGF2 solution for 10 minutes at 4°C in an orbital 
shaker (45 rpm, MaxQ 8000, Thermo, US) and then lyo-
philized (Alpha 1–4 LSC, Chirst, Germany) at −50°C over-
night to obtain three types of FGF2-immobilized samples. 
The immobilization procedures were repeated thrice.
Surface analysis
The FGF2 on the NT-F-L/M/H samples was examined by an 
immunofluorescence assay.24 After FGF2 immobilization, the 
samples were gently washed thrice with phosphate buffered 
saline (PBS, pH = 7.4) for 5 minutes, treated with rabbit 
anti-bFGF polyclonal antibody (1:200; Sigma-Aldrich) as 
the primary antibody at 4°C overnight, and washed thrice 
with PBS. The samples were then treated with fluorescein 
isothiocyanate-labeled goat antirabbit immunoglobulin G 
(1:200; Bois, People’s Republic of China) for 1 hour at 
37°C and washed thrice in PBS (pH = 7.4). The samples 
were inspected by laser confocal microscopy (Olympus 
FV-1000, Japan). In order to evaluate the remaining FGF2 
on the nanotubular surface over a specific time interval, a 
portion of the FGF2 immobilized samples was incubated in 
PBS at 37°C for 9 days (with a change in PBS every 3 days), 
and then the immunofluorescence procedures were repeated 
as described previously.
To measure the elution of FGF2 versus time, samples 
were immersed in PBS (1 mL per sample) at 4°C (to preserve 
the activity of FGF2) for 1 day, 2 days, 3 days, 4 days, 6 days, 
9 days, 15 days, 21 days, or 30 days. Utilizing the standard 
curve of FGF2, the FGF2 concentrations in the extracts were 
determined by the enzyme-linked immunosorbent assay 
(Quantikine® Human FGF Basic Immunoassay, R&D, US), 
and the amounts of dissolved FGF were also calculated.
Surface characterization
Surface and material characterization was conducted on 
five types of samples. Field emission scanning electron 
microscopy (FE-SEM; JSM-6460, JEOL, Japan) and atomic 
force microscopy (AFM; SPM400, SEIKO, Japan) were 
employed to observe and measure (Adobe Photoshop CS2) 
the surface microstructure as well as surface roughness.
Behavior of HgFs
The HGFs were obtained from three periodontally healthy 
patients (aged 19 years, 33 years, and 46 years) undergoing 
crown-lengthening surgery. Ethical approval and consent was 
obtained from all three volunteers. The gingival tissues were 
washed in PBS containing 100,000 U penicillin/gentamicin 
twice and incubated in 1 U/mL Dispase® II solution (Roche, 
US) overnight to separate the connective tissues from the 
epithelium. The tissues were then sheared into 1.0 mm3 cubes 
cultured in Dulbecco’s modified Eagle’s medium (DMEM, 
Gibco) with 10% fetal calf serum (FCS, Gibco) and 100,000 
U penicillin/gentamicin (Roche) and incubated in a humidi-
fied atmosphere of 5% CO2 at 37°C.
HGFs at passage 4 were used for further analysis. The 
1 mL HGF suspension was seeded on each sample (serum-
free) at the density 1 × 105 cells/mL (∼5 × 104 cells/cm2) 
and cultured for 30 minutes, 60 minutes, or 120 minutes to 
allow attachment. At each time interval, the samples were 
washed with PBS to remove nonattaching cells. Afterwards, 
the attached cells were fixed in 4% formalin and stained with 
4′,6′-diamidino-2-phenylindole (DAPI; 1 µg/mL; Roche).12 
The images were captured from the four corners and the 
center of each sample (2.60 mm × 1.94 mm, five fields per 
sample) using a fluorescence microscope (Leica DMI6000B, 
Germany). Three of five images were randomly selected (by 
random number table). Image J software (National Institutes 
of Health) was employed to convert the original images to 
binary images, and black particles were counted to obtain 
the number of attached cells. The results were calculated as 
relative cell attachment rates (RCARs) to balance the height 
of data bars among groups as follows:
RCAR,% = (COUNTT/COUNTP) × 100%, where 
COUNTT represents the mean value of the cell number 
counted on the tested samples and COUNTP is the mean 
value of the cell number on the PT control.
Cell proliferation was evaluated by the methyl-thiazolyl-
tetrazolium (MTT) bromide assay. Briefly, five groups of 
samples (three samples per group) were placed in a 24-well 
dish (Costar 3524, US) and 4 × 104 HGF cells were seeded in 
each well and cultured in DMEM with 10% bovine calf serum. 
On Day 1, Day 3, Day 6, and Day 9, the samples were gently 
washed three times with PBS and placed on a new 24-well 
dish. The MTT-PBS (Amresco, US) solutions (5 mg/mL) were 
prepared and filter sterilized. The MTT solution (200 µL) and 
serum-free/phenol red-free DMEM (800 µL) were added to 
each well and the samples were incubated at 37°C for 4 hours 
to form formazen. Afterwards, formazen was dissolved in 
dimethyl sulfoxide (DMSO; 1 mL/well). Two hundred micro-
liters of the mixed solution was transferred to a new 96-well 
dish and the optical density value of each well was monitored 
at 490 nm using a spectrophotometer (Bio-tek, US).12,18
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1967
Biomodified TiO2 in dental implant abutmentInternational Journal of Nanomedicine 2012:7
Morphological observation of HgFs
A 1 mL cell suspension at a density of 2 × 104 cells/mL 
was seeded on each sample and cultured in DMEM with 
10% bovine calf serum. After 3 days, the samples were 
fixed in a 2.5% glutaraldehyde solution. After a series of 
dehydration (in graded acetone and isoamyl acetate) and 
desiccation (lyophilization), the samples were gold-coated 
and the cell morphology was observed by FE-SEM (JSM-
6460, JEOL).
ECM-related gene expression
Expressions of the ECM-related genes were analyzed using 
quantitative real-time polymerase chain reaction (RT-PCR). 
The HGFs were cultured in the same manner as described in 
the proliferation assay. The total RNA of each sample was 
extracted with TRIzol reagent (Invitrogen). One microgram 
total of RNA from each sample was reverse transcribed 
into complementary DNA (cDNA, 50 µL system) using the 
PrimeScriptTM RT reagent kit (TaKaRa, Japan). Quantitative 
PCR was conducted on the ABI7500 RT-PCR system to 
determine the mRNA relative expression of the ECM-
related genes including vascular endothelial growth factor A 
(VEGFA), β-integrin (ITGB), intercellular adhesion molecule 
1 (ICAM1), and laminin-1 (LAMA1) using SYBR® Premix 
ExTM TaqII (TaKaRa). The forward/reverse primers for the 
selected genes are listed in Table 1. The PCR efficiency 
was compared. The relative expression levels for each gene 
of interest were normalized to the expression of the house-
keeping gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) by calculating the change (∆) in cycle threshold 
(Ct): ∆Ct = (Ctgene of interest – CtGAPDH), and the expression of the 
different genes was expressed as 2−(∆Ct). The gene expression 
of PT as the control was normalized to 1.31 The specificity of 
every pair of PCR primers was confirmed by analyzing the 
melting curves, and the data were analyzed using the Applied 
Biosystem Software in the Excel® format.
Bioactivity changes of immobilized FgF2
To evaluate the bioactivity changes of FGF2 after repeated 
lyophilization, 1000 ng of FGF2 was pretreated with three 
cycles of lyophilization dissolution and diluted to 10 ng/mL 
in 100 mL of DMEM (serum-free). The FGF2-loaded 
DMEM was divided into five groups and stored at 37°C 
to be used at five different time intervals: newly prepared 
(NP) and S1, S3, S6, S9 (stored for 1 day, 3 days, 6 days, 
and 9 days, respectively). The PT samples were placed in 
24-well dishes (three samples per group), and 4 × 104 HGF 
cells were seeded on each well. The samples were cultured in 
FGF2-free DMEM or one of the five types of FGF2-loaded 
DMEM. After 24 hours, the samples were placed in a new 
24-well dish, and the proliferation activity was monitored 
using the MTT assay as described previously.
Statistical analyses
The data were analyzed using SPSS 18.0 software (SPSS, 
Inc, Chicago, IL). The statistical results were presented as 
means ± standard deviation and analyzed by one-way analy-
sis of variance followed by a Student-Newman-Keuls post 
hoc test to identify significant differences among the groups 
(multiple comparisons).12 When the probability value (P) was 
less than 0.01, the difference was regarded as significant.
Results
Surface characterization
The FGF2-immobilized surfaces (NT-F-L/M/H) generated 
fluorescence both initially and after 9 days, but no fluores-
cence was observed from the PT or NTs (Figure 1). FGF2 
was found to be immobilized on the TiO2 nanotubular surface 
and remained so for a certain period of time. The surface 
morphology of the samples is displayed in Figure 2 (FE-
SEM) and Figure 3 (AFM). On the nanoscale, the TiO2 NTs 
are organized in a vertical array with a diameter of ∼100 nm 
(Figure 2A) and tube length 588.8 ± 31.92 nm (Figure 2B). 
On the FGF2-immobilized nanotubular surfaces, FGF2 
Table  1 Target  cDNA  primer  sequences  used  in  quantitative 
polymerase chain reaction
VEGFA
  Forward: 5′-gAgCCTTgCCTTgCTgCTCTAC-3′
  Reverse: 5′-CACCAgggTCTCgATTggATg-3′
  PCR product size: 148 bp
ITGB
  Forward: 5′-TgTgTCAgACCTgCCTTggTg-3′
  Reverse: 5′-AggAACATTCCTgTgTgCATgTg-3′
  PCR product size: 105 bp
ICAM1
  Forward: TgAgCAATgTgCAAgAAgATAgC
  Reverse: CCCgTTCTggAgTCCAgTACA
  PCR product size: 105 bp
LAMA1
  Forward: TggTAACATTTgCCACCACgA
  Reverse: TTgCCTCCgATCAgCATgAC
  PCR product size: 127 bp
GAPDH (housekeeping gene)
  Forward: 5′-gCACCgTCAAggCTgAgAAC-3′
  Reverse: 5′-TggTgAAgACgCCAgTggA-3′
  PCR product size: 138 bp
Abbreviations: GAPDH, glyceraldehyde 3-phosphate dehydrogenase; ICAM1, inter-
cellular adhesion molecule 1; ITGB,  β-integrin; LAMA1, laminin-1; VEGFA, vascular 
endothelial growth factor A.
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Initial
PT
PT
40X
40X
Day 9
NT
NT
NT-F-L
NT-F-L
NT-F-M
NT-F-M
NT-F-H
NT-F-H
Figure 1 Immobilized FgF2 compared with FgF2-free samples initially and after 9 days. 
Abbreviations: FGF2, fibroblast growth factor 2; NT, nanotube; PT, polished titanium.
588.85 ± 3.92nm
B
Figure 2 Field emission scanning electron microscopy results. (A) NT surface showed an NT array structure; NT-F-H surface showed clumps of fibroblast growth factor 2 
and that the typical NT surface was changed. (B) Profile of titania NT. 
Note: The length of NT was 588.85 ± 31.92 nm (mean value ± standard deviation). 
Abbreviations: NT, nanotube; PT, polished titanium.
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adsorbs on to the TiO2 NT walls homogeneously on NT-F-L 
and NT-F-M. The morphology is evidently different from 
that of NT-F-H. The FGF2 on NT-F-H manifested as clumps 
or cord-like aggregates with a nonuniform distribution. On 
the microscale, PT demonstrated a microgroove-like surface 
structure that was a lot rougher than the other four types of 
NT-based surfaces that have similar nanoporous structures. 
Anodization produced a smooth Ti surface, whereas the 
surface roughness barely changed after FGF2 immobilization 
(Figure 3 and Table 2).
Elution kinetics of immobilized FgF2
Results of the elution kinetics are shown in Figure 4 and 
Table 3. The immobilized FGF2 was released from all 
the samples rapidly within the first 3 days, followed by a 
gradual reduction in the elution rate. On Day 9, over 90% 
of the dissolvable immobilized FGF2 had been eluted (with 
the total amount of dissolvable FGF2 in 30 days considered 
100% likely elution). Almost all the dissolvable FGF2 was 
eluted in 21 days, after which (up to 30 days) the amount of 
additional elution was negligible.
Behavior of HgFs
The HGF adhesion assay results are displayed in Figure 5A, 
and the RCAR results are shown in Figure 5B. The number 
of adhered cells on the NT-F-L and -M are significantly 
larger than those on the PT, NT, or NT-F-H at 30 minutes, 
60 minutes, and 120 minutes (P , 0.01). NT-F-M shows the 
highest cell adhesion among the tested samples. Cell adhesion 
on NT and NT-F-H samples is significantly suppressed 
(,50%) compared with PT. The TiO2 NT array without 
FGF2 or with over FGF2 immobilization appears to impair 
HGF adhesion.
The results of the cell proliferation study are depicted 
in Figure 6. Compared with PT, NT-F-L and NT-F-M have 
enhanced HGF proliferation at all time points, whereas NT 
shows enhanced proliferation on Day 3 only (P , 0.01). 
NT-F-H exhibited extremely low cell proliferation on 
Days 1 and 3, but improved HGF proliferation was noted 
on Days 6 and 9. Nevertheless, the enhanced effect of 
NT-F-H was not as substantial as that observed from NT-F-L 
and NT-F-M. The morphology of HGFs on the samples 
is displayed in Figure 7. The observed morphological 
differences of HGFs among the PT, NT, NT-F-L, and NT-
F-M samples are slight. The HGFs on the NT-F-H surface 
were narrow, with fewer prominences or pseudopods under 
normal conditions. Furthermore, HGFs on the NT-F-H sur-
face did not fuse together or demonstrate any trend to form 
tissue-like structures during the time.
Adequate ECM-related gene expression is expected to 
realize wound healing and tissue regeneration. The results 
of ECM-related gene expression on different surfaces are 
shown in Figure 8. The HGFs on NT-F-L and NT-F-M show 
Figure 3 Atomic force microscopy images of different surfaces: (A) PT, (B) NT, 
(C) NT-F-L, (D) NT-F-M, and (E) NT-F-H. PT showed a microgroove structure, and 
porous-like structures were observed in other groups. 
Abbreviations: NT, nanotube; PT, polished titanium.
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Figure 4 Elution kinetics of various FgF2 immobilizations. FgF2 eluted rapidly 
within first 3 days and the elution velocity reduced with time. Approximately all 
dissolvable FgF2 eluted within 30 days. 
Abbreviations: FGF2, fibroblast growth factor 2; NT, nanotube.
Table  2  Measurement  of  surface  roughness  by  atomic  force 
microscopy
Group Ra RMS
PT 32.60 ± 3.45 nm 41.70 ± 3.96 nm
NT   4.96 ± 0.50 nm*   6.23 ± 0.80 nm*
NT-F-L   7.25 ± 0.97 nm*   9.14 ± 1.25 nm*
NT-F-M   9.70 ± 1.85 nm* 11.80 ± 2.21 nm*
NT-F-H   9.42 ± 1.99 nm* 11.79 ± 2.35 nm*
Notes: *Lower Ra and RMS compared with PT (P , 0.01). Anodization significantly 
smoothed titanium surface, whereas surface roughness was barely affected by FgF2 
immobilization.
Abbreviations: FGF2, fibroblast growth factor 2; NT, nanotube; PT, polished titanium; 
Ra, average roughness, RMS, root mean square roughness.
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Table 3 Elution of dissolvable FgF2 at different time intervals*
Time interval NT-F-L NT-F-M NT-F-H
Mass  
(ng)
Percent  
(accumulative)
Mass  
(ng)
Percent  
(accumulative)
Mass  
(ng)
Percent 
(accumulative)
D0∼D1 10 36.76 24 36.70 35.6 41.59
D1∼D2 6 58.82 14.1 58.26 16.5 60.86
D2∼D3 3 69.85 7.9 70.34 8.9 71.26
D3∼D6 4.5 86.40 11.5 87.92 15.5 89.37
D6∼D9 1.5 91.91 4.5 94.80 5.7 96.03
D9∼D15 1.4 97.06 2.3 98.32 2.1 98.48
D15∼D21 0.6 99.26 0.7 99.39 0.8 99.42
D21∼D30 0.2 100.00 0.4 100.00 0.5 100.00
Notes: *Average amounts and accumulative percent of eluted FGF2 at each time interval. FGF2 rapidly eluted within the first 3 days, followed by a gradual reduction in 
elution. Over 90% of the dissolvable immobilized FgF2 eluted within 9 days. After 21 days, additional elution was negligible.
Abbreviations: FGF2, fibroblast growth factor 2; NT, nanotube; PT, polished titanium.
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Figure 5 HgF adhesion. (A) HgFs attached to the substrates with 4′,6′-diamidino-2-phenylindole stain and (B) relative cell adhesion rate of attached HgFs. The NT and 
NT-F-H surfaces inhibited cell adhesion, whereas the NT-F-L and NT-F-M improved cell attachment. 
Notes: #Higher than PT (P , 0.01), *lower than PT (P , 0.01), difference also exists between 1*, 2*, 1#, and 2# (P , 0.01). 
Abbreviations: HGF, human gingival fibroblast; NT, nanotube; PT, polished titanium.
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beneficial ECM-related gene expression, and the details of the 
ECM-related gene expressions are summarized in Table 4.
Bioactivity changes of immobilized FgF2
The changes in bioactivity of immobilized FGF2 are shown in 
Figure 9. The activity of FGF2 was not significantly affected 
by repeated lyophilization-dissolving cycles but reduced 
gradually over time (NP ≈ S1 . S3 ≈ S6 . S9) at 37°C. After 
storing for 9 days (S9), the activity of FGF2 was reduced to 
less than 50% compared with NP. Proteolytic degradation 
may be the main reason for the loss of activity due to the 
absence of the protective ECM component32 in DMEM.
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NIN NIN SEI 5.0 kV ×1,500 10 µm WD 7.7 mm SEI 5.0 kV ×1,500 10 µm WD 7.7 mm NIN SEI 5.0 kV ×1,500 10 µm WD 7.7 mm
NIN SEI 5.0 kV ×1,500
NIN SEI 5.0 kv ×10,000 1 µm WD 7.7 mm NIN SEI 5.0 kv ×10,000 1 µm WD 7.7 mm NIN SEI 5.0 kv ×10,000 1 µm WD 7.7 mm
NIN SEI 5.0 kv ×10,000 1 µm WD 7.5 mm NIN SEI 5.0kv ×10,000 1 µm WD 7.6mm
10 µm WD 7.6 mm NIN
NT-F-L NT-F-M NT-F-H
PT NT
SEI 5.0 kV ×1,500 10 µm WD 7.6 mm
Figure 7 Morphology of HgFs: (A) PT, (B) NT, (C) NT-F-L, (D) NT-F-M, and (E) NT-F-H lacking sufficient prominences/pseudopods and not fusing together. 
Abbreviations: HGF, human gingival fibroblast; NT, nanotube; PT, polished titanium.
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Figure 6 Cell proliferation measured by the methyl-thiazolyl-tetrazolium assay. NT-F-L 
and NT-F-M showed the higher cell proliferation at each interval, whereas NT-F-H with 
overimmobilized FgF2 showed the lowest at the early stage (Days 1 and 3). 
Notes: #Higher than PT (P , 0.01), *lower than PT (P , 0.01), significant difference 
exists between 1# and 2# (P , 0.01). 
Abbreviations: FGF2, fibroblast growth factor 2; NT, nanotube; OD, optical density; 
PT, polished titanium.
Discussion and conclusion
Unlike previous methods used to prepare microscale porous 
TiO2 films,33,34 in the present study, F+-based electrolyte 
anodization was used to obtain the TiO2 nanotubular   surface 
on dental implants. However, in the transgingival part of 
a Ti dental implant, a smooth surface helps to maintain 
cleanliness. It has been shown that various types of cells 
have dissimilar reactions to different nanotubular surfaces 
of disparate tube sizes.14–16,18,35 Sterilization also affects the 
cytocompatibility of the TiO2 surface, and ultraviolet irradia-
tion is one of the methods to improve the bioactivity of TiO2 
without unexpected biological contamination.35
Application of FGF2 to periodontal tissue regeneration 
has been previously reported.36,37 FGF2 can be immobilized 
on to Ti surface24 and hydroxyapatite-chitosan scaffolds.38 
The immobilization procedure used in this study as well as 
the chemical inertness and stability of TiO2 ensure that there 
is very little possibility for the FGF2 to react with the TiO2 
NT array. Besides, using a TiO2 nanotubular surface for 
long-term drug elution is feasible due to its multitubular-like 
structure and ability to trap relatively small amounts of drug.25 
FGF2 (17 kDa) is approximately 1.45 nm39 in hydrodynamic 
radius, and a biomolecule with such a small size is more likely 
to enter the inner space of the TiO2 NTs (Figure 10). Intratube 
FGF2 storage may provide the possibility for an NT-based 
control release system. Although the total amount of immo-
bilized FGF2 is difficult to quantify accurately, the elution 
kinetics of dissolvable immobilized FGF2 can be monitored 
with an enzyme-linked immunosorbent assay. The elution 
curves in this study are similar to those reported previously 
by Peng et al,25 indicating that the length of the NT mainly 
affects the controlled release of immobilized FGF2.
Compared with PT, NT and NT-F-H exhibit significantly 
suppressed cell adhesion probably because of the surface 
physicochemical properties and nanotopography. The 
TiO2 NT array has a multiringed shape with small initial 
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  cell-substrate contact areas. The hollow structure of the TiO2 
NT array may also inhibit the formation of focal adhesion. 
Integrin clustering and focal adhesion reinforcement are not 
influenced by the nanoscale pits with a diameter of ,70 nm 
irrespective of pit depth. However, increasing the size of 
the central lumen to .70 nm in these vertically aligned NTs 
significantly reduces cellular adhesion.15,40 In this study, 
the attachment of HGFs is better on NT-F-L and NT-F-M 
than on NT, probably due to FGF2 immobilization. This 
offers   functional regions to accelerate cell attachment and 
increases the contact area between the cells and substrate. 
The main reason for the suppressed HGF attachment on 
NT-F-H may be the direct contact with the clumps of FGF2 
on NT-F-H with over FGF2 immobilization. According to 
FE-SEM results and FGF2 elution kinetics, when the samples 
are immersed in the culture medium, the clumps of FGF2 
  dissolve rapidly, leaving the HGFs with a relatively unstable 
environment and making HGFs hard to attach.
Inverse concentration-dependent effect has been observed 
in the proliferation of HGFs on NT-F-H, which was much 
less than that on PT on Days 1 and 3, but gradually increased 
by Days 6 and 9. On the contrary, both NT-F-L and NT-F-M 
demonstrated excellent performance in terms of proliferation 
at all time points. Our results illustrate the enhanced behavior 
of fibroblasts in a medium with the appropriate concentration 
of eluted FGF2. Referring to the results in Figure 9 and 
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Figure 8 Extracellular matrix-related gene expressions by HgFs cultured on four different titanium surfaces at Days 3, 6, and 9: (A) VEGFA, (B) ITGB, (C) ICAM1, and   
(D) LAMA1. Inverse concentration-dependent effects of NT-F-H were observed at Day 3 on (C) and (D). 
Notes: #Upregulated compared with PT (P , 0.01), *downregulated (P , 0.01), significant difference exists between 1*, 2*, 1#, and 2# (P , 0.01). 
Abbreviations: HGF, human gingival fibroblast; ICAM1, intercellular adhesion molecule 1; ITGB, β-integrin; LAMA1, laminin-1; NT, nanotube; PT, polished titanium;   
VEGFA, vascular endothelial growth factor A.
Table 4 Summary of extracellular matrix-related gene expressions on Days 3, 6, and 9
VEGFA ITGB ICAM1 LAMA1
D3 D6 D9 D3 D6 D9 D3 D6 D9 D3 D6 D9
NT + + + + + + / / / + +2 /
NT-F-L +2 +2 +2 +3 +2 +2 / / / +2 +3 +
NT-F-M +3 +2 +4 +4 +4 +2 + + + +2 +3 +
NT-F-H +4 +3 +3 +2 +3 +2 − +2 + − + +
Notes: +, Upregulated compared with PT (P , 0.01); −, downregulated (P , 0.01); /, no significant difference compared with PT.
Abbreviations: ICAM1, intercellular adhesion molecule 1; ITGB, β-integrin; LAMA1, laminin-1; NT, nanotube; PT, polished titanium; VEGFA, vascular endothelial growth factor A.
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Table 3, the activity and concentrations of eluted FGF2 from 
NT-F-L, -M, and -H are all suitable for cell proliferation within 
3 days (10–100 ng/mL),22 whereas NT-F-H shows extremely 
low proliferation. An unstable microenvironment is probably 
the main reason for this suppressive effect. On the NT-F-H 
surface, FGF2 dissolves within the first day and impedes the 
attachment of HGFs, therefore delaying their   proliferation 
when compared with those on NT-F-L and NT-F-M. 
In all organ systems, the normal mammalian response to 
injury occurs in three overlapping but distinctive stages: (1) 
inflammation, (2) new tissue formation, and (3)   remodeling. 
Stage 1 lasts for about 2 days after injury, whereas Stage 2 
occurs 2–10 days after injury and is characterized by   cellular 
proliferation.41 Therefore, early proliferation of HGFs after 
implantation is crucial to healthy soft tissue sealing, and 
concentration-related impeded proliferation should be 
avoided.
In the morphogenesis of virtually all tissues, the ECM 
is essential and forms a structural framework possessing 
signal-transducing receptors that interact with cells. VEGFA 
enhances blood vessel growth and permeability and is a 
powerful mitogen for endothelial cells, fulfilling an important 
role in angiogenesis.42,43 Hence, an FGF2-immobilized TiO2 
nanotubular surface may promote vascularization and further 
accelerate soft tissue regeneration around dental implants. 
In this work, the VEGFA expressions of NT, NT-F-L, -M, 
and -H are all upregulated, and NT-F-H shows the highest 
expression on Days 3 and 6. Overexpression of VEGFA may 
produce tissue inflammation or edema, thereby delaying 
tissue regeneration.
Integrins constitute the primary family of cell-surface 
receptors that mediate attachment to the ECM and substrates44 
and play a key role in early signal transduction.45 In the 
integrin family, β-integrin is important in cellular binding on 
coated or textured Ti implants.46 The total ITGB expression 
levels are concentration-dependent and increased by FGF2.47 
In this study, NT-stimulated ITGB is overexpressed at 
all time points, because the nanotubular surface hinders 
cellular attachment in the early stage but improves ITGB 
expression due to reverse compensation. NT-F-L, -M, 
and -H significantly enhance ITGB expression at all time 
intervals, and NT-F-M shows the highest gene expression 
among them on Days 3 and 6. However, this trend is not 
observed at Day 9. The probable reason may be that ITGB is 
richly expressed during the early stages. After cell-material 
integration has occurred, the expression of ITGB is less 
sensitive to the various concentrations of FGF2. Unlike 
VEGFA expression, excessive FGF2 does not give rise to a 
reverse effect but cannot fully exert its bioactivity. The TiO2 
nanotubular surface is probably the main factor regulating 
ITGB expression after Day 9.
ICAM1, which is a widely expressed cell adhesion 
molecule48–50 and belongs to the immunoglobulin super 
family, plays an important physiological role in routing 
polymorphonuclear neutrophils to the gingival sulcus 
efficiently and initiating a host response toward the implant. 
The expression of endothelial cell adhesion molecules 
(CAMs) for leukocytes, P-selectin, E-selectin, and ICAM1 
is significantly upregulated in inflamed tissues by FGF2.51 
Our results reveal that the TiO2 nanotubular surface does 
not affect ICAM1 expression, and even the NT-F-L’s 
efficacy is nil. It is only when the concentration of FGF2 
reaches a certain threshold that the effect is observed, 
Figure 10 Pattern of nanotube-based FgF2 control release system: (A) initial stage, 
(B) in culture medium, FgF2 is gradually released from the nanotubes. 
Abbreviation: FGF2, fibroblast growth factor 2.
0.35
0.30
0.25
0.15
0.20
0.10
0.05
0
24 H
O
D
 
v
a
l
u
e
Control
Activity of dissolvable FGF2
3#
2#
1#
S1
NP
S3
S6
S9
Figure 9 Activity changes of dissolvable FGF2 (10 ng/mL): control (FGF2-free); 
newly prepared Dulbecco’s modified Eagle’s medium; and S1, S3, S6, and S9 (FGF2 in 
Dulbecco’s modified Eagle’s medium stored for 1 day, 3 days, 6 days, or 9 days, 
respectively). The activity of FgF2 reduced gradually in culture medium with time 
and dropped to less than 50% after 9 days (S9) compared with NP. 
Note: #Higher than PT (P , 0.01), significant difference exists between 1#, 2#, and 3# 
(P , 0.01).
Abbreviations: FGF2, fibroblast growth factor 2; NT, nanotube; OD, optical density; 
PT, polished titanium.
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thereby impairing (NT-F-H, Figure 8C, Day 3) or enhancing 
(NT-F-M Figure 8C, Days 3, 6, and 9; NT-F-H, Figure 8C, 
Days 6 and 9) ICAM1 expression. This effect may result in 
the increase of intercellular adhesion in the early stage as 
well as recruitment of polymorphonuclear neutrophils to 
produce anti-infective activity in the long term,50 thereby 
improving the microecological environment around the 
dental implant.
Laminins are CAMs found predominantly in basement 
membranes52 and may help to form a base for cell-substrate 
adhesion and improve the interface between cells (even epi-
thelium) and dental implants. The mRNA levels of laminin 
in periodontal ligament cells are specifically upregulated 
by FGF2 stimulation.36 In this study, both the TiO2 nano-
tubular surface and FGF2 exhibit stimulated the LAMA1 
expression. The inverse concentration-dependent effect 
was significantly observed on NT-F-H on Days 3 and 6 but 
diminished on Day 9.
From the perspective of cell adhesion, proliferation, and 
ECM-related gene expression, our results reveal that the 
functions of FGF2 immobilized on TiO2 nanotubular surface 
are definitely bidirectional as well as concentration- and 
time-dependent. The FGF2 solution with a concentration 
of 500 ng/mL is optimal for repeated lyophilization in spite 
of some loss of bioactivity with time. The TiO2 nanotubular 
surface might be ideal because its microstructure facilitates 
FGF2 immobilization, storage, and controlled release within 
9 days. However, overimmobilization of FGF2 could lead to 
unwanted impairment of tissue healing and must therefore 
be avoided. Although the NT-based drug control release 
system needs further research for optimization, this FGF2/
TiO2 nanotubular surface (NT-F-M) modification may lead 
to excellent gingival tissue-implant integration in vivo and 
has promising applications in dentistry and other biomedi-
cal devices.
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